Cargando…
Intrarenal Renin-Angiotensin-System Dysregulation after Kidney Transplantation
Angiotensin-converting enzyme inhibitors (ACEis) are beneficial in patients with chronic kidney disease (CKD). Yet, their clinical effects after kidney transplantation (KTx) remain ambiguous and local renin-angiotensin system (RAS) regulation including the ‘classical’ and ‘alternative’ RAS has not b...
Autores principales: | Kovarik, Johannes J., Kaltenecker, Christopher C., Kopecky, Chantal, Domenig, Oliver, Antlanger, Marlies, Werzowa, Johannes, Eskandary, Farsad, Kain, Renate, Poglitsch, Marko, Schmaldienst, Sabine, Böhmig, Georg A., Säemann, Marcus D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611786/ https://www.ncbi.nlm.nih.gov/pubmed/31278281 http://dx.doi.org/10.1038/s41598-019-46114-x |
Ejemplares similares
-
Molecular remodeling of the renin-angiotensin system after kidney transplantation
por: Antlanger, Marlies, et al.
Publicado: (2017) -
Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory Study
por: Kovarik, Johannes J., et al.
Publicado: (2021) -
Combined sodium glucose co‐transporter‐2 inhibitor and angiotensin‐converting enzyme inhibition upregulates the renin‐angiotensin system in chronic kidney disease with type 2 diabetes: Results of a randomized, double‐blind, placebo‐controlled exploratory trial
por: Antlanger, Marlies, et al.
Publicado: (2022) -
Neprilysin is a Mediator of Alternative Renin-Angiotensin-System Activation in the Murine and Human Kidney
por: Domenig, Oliver, et al.
Publicado: (2016) -
Empagliflozin in posttransplantation diabetes mellitus: A prospective, interventional pilot study on glucose metabolism, fluid volume, and patient safety
por: Schwaiger, Elisabeth, et al.
Publicado: (2019)